FAK is overexpressed in a large number of human cancers (50–80% of all solid tumors1) and modulates multiple hallmarks of cancer, including invasion, metastasis, resistance to apoptosis, proliferation, glycolysis, angiogenesis, and immune inactivation2–5. The gene discussed is PTK2; the disease is cancer.